Lobbyists Urge for a National Centre for Asbestos Related Disease

Posted on Tuesday 26 May 2009

According to Chris Knighton of the Mick Knighton Mesothelioma Research Fund, one of the asbestos related diseases, mesothelioma, which is a cancer of the lining of the lungs, causes over 2000 deaths every year in the UK alone and the number is not showing any sign of decline.

The lobbyists are now demanding for adequate research in this field, in order to come up with new cures to combat asbestos related diseases. In their latest initiative, a petition signed by over 24, 000 people, was submitted to the Prime Minister at his residence, located at 10 Downing Street.

The main demands highlighted in the petition were funding to the tune of £7m towards establishment of a research institute dedicated to the study of asbestos related diseases and their cures. This centre is intended to provide funding to launch full-fledged research into various aspects of asbestos related issues under the supervision of experts in the field, as against the currently unorganized research works operating with public funding and donations.

People directly engaged in manufacturing and other industries where there is direct exposure to asbestos are at the biggest risk, and this is the segment of people suffering the most. It is expected that a grant from the Government will encourage expert researchers and medical practitioner to join the cause, which will be a major boost. The proposed Centre, it is hoped, will help cure people or prolong the lifetime of thousands of workers whose lives have been affected by asbestos.

Avoid unexpected accidents by having staff properly trained by the experts at Workplace Law. Find out more about their well regarded dse courses.

Share this with friends: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • OnlyWire
  • Socialize-It
  • Digg
  • del.icio.us
  • Furl
  • StumbleUpon
  • Netscape
  • YahooMyWeb
  • Reddit
  • Slashdot
  • Ma.gnolia
  • RawSugar

Sorry, the comment form is closed at this time.